Compare CYTK & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | IDA |
|---|---|---|
| Founded | 1997 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.8B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | IDA |
|---|---|---|
| Price | $62.41 | $128.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $82.38 | ★ $135.43 |
| AVG Volume (30 Days) | ★ 2.2M | 410.2K |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | N/A | ★ 7.17 |
| EPS | N/A | ★ 5.84 |
| Revenue | $87,211,000.00 | ★ $1,805,885,000.00 |
| Revenue This Year | $346.43 | $6.64 |
| Revenue Next Year | $57.69 | $8.06 |
| P/E Ratio | ★ N/A | $21.94 |
| Revenue Growth | ★ 2609.26 | N/A |
| 52 Week Low | $29.31 | $104.74 |
| 52 Week High | $70.98 | $138.03 |
| Indicator | CYTK | IDA |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 52.11 |
| Support Level | $62.05 | $124.81 |
| Resistance Level | $66.59 | $129.59 |
| Average True Range (ATR) | 2.97 | 1.94 |
| MACD | 0.09 | 0.21 |
| Stochastic Oscillator | 33.47 | 67.01 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.